Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 55

Results For "central"

756 News Found

Merck KGaA to expand its membrane and filtration manufacturing facility in Ireland
News | May 23, 2022

Merck KGaA to expand its membrane and filtration manufacturing facility in Ireland

The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland


Pharma companies with ESG more valuable say investors
Sustainability | May 20, 2022

Pharma companies with ESG more valuable say investors

When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’


Motilal Oswal Private Equity (MOPE) invests  in Pathkind Diagnostics
Clinical Trials | May 20, 2022

Motilal Oswal Private Equity (MOPE) invests in Pathkind Diagnostics

A primary investment of Rs 194.4 crore has been made


CDSCO approves Jardiance for heart failure with preserved ejection fraction
Drug Approval | May 19, 2022

CDSCO approves Jardiance for heart failure with preserved ejection fraction

With the approval from the Central Drugs Standard Control Organisation (CDSCO), Jardiance is now the first approved therapy to improve outcomes for the full spectrum of heart failure regardless of ejection fraction


Dr Mansukh Mandaviya promises to introduce `Made in India’ TB infection skin test kit
Public Health | May 19, 2022

Dr Mansukh Mandaviya promises to introduce `Made in India’ TB infection skin test kit

This cost-effective tool will be of immense benefit to other high burden countries as well.


PCI Pharma Services announces US $100 million investment in New England
Biotech | May 13, 2022

PCI Pharma Services announces US $100 million investment in New England

Capabilities include the latest in sterile lyophilization and liquid filling technology to support global pharmaceutical supply chain, keeping pace with industry trends


First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial
Biotech | May 12, 2022

First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial

CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng


Lupin selects HPE GreenLake edge-to-cloud platform
Digitisation | May 09, 2022

Lupin selects HPE GreenLake edge-to-cloud platform

Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss


Thalassemia children require comprehensive treatment approach: Dr Sunil Bhat, Narayana Health City
Public Health | May 08, 2022

Thalassemia children require comprehensive treatment approach: Dr Sunil Bhat, Narayana Health City

There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous


SKS Hospital, Salem installs Carestream’s detector for paediatric studies
Hospitals | May 07, 2022

SKS Hospital, Salem installs Carestream’s detector for paediatric studies

This newly designed small-format detector is made up of caesium iodide technology and is extremely high in resolution, capable of capturing the fine detail of smaller anatomical structures present in paediatric patients